Table 2.
Outcome measures across treatment groups
| VARIABLE | CONTROL GROUP (N = 105), N (%)* | INTERVENTION GROUP (N = 105), N (%)* | P VALUE |
|---|---|---|---|
| Numeracy score | .84† | ||
| • 0 | 45 (44.6) | 43 (41.0) | |
| • 1 | 44 (43.6) | 50 (47.6) | |
| • 2 | 12 (11.9) | 12 (11.4) | |
| FOBT cards taken | 72 (70.3) | 77 (73.3) | .96 |
| CRC screening discussion documented by physician | 52 (51.5) | 57 (54.3) | .75 |
| FOBT recommended by physician | 9 (8.9) | 11 (10.5) | .71 |
| Flexible sigmoidoscopy recommended by physician | 1 (1.0) | 1 (1.0) | .98 |
| Colonoscopy recommended by physician | 49 (48.5) | 56 (53.3) | .49 |
| Barium enema recommended by physician | 7 (6.9) | 4 (3.8) | .32 |
| FOBT completed | 10 (9.9) | 7 (6.7) | .38 |
| Colonoscopy completed | 21 (20.8) | 22 (21.0) | .95 |
| Completed any CRC screening tests | 28 (27.7) | 27 (26.7) | .66 |
CRC—colorectal cancer, FOBT—fecal occult blood test.
*
Proportions are calculated excluding missing data and might not add to 100% owing to rounding.
†
Fisher exact test performed in lieu of χ2 test.